Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

Publisher Name: Analyst View Market Insights
No. of Pages: 68
Publication Month:
Jul-17

REPORT HIGHLIGHT
The “Global Biosimilars Market- – Industry Analysis, Share, Trend, Market Size and Forecast” was estimated to be around US$ 50.0 billion in 2016 and is anticipated to grow with 55.0% of growth rate during the future period. This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.
In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period. The rise in the aging population, increasing cancer patients, and rise of hospital acquired infection patients globally are factors responsible for the growth of this application segment. The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The report aims at estimating the market size and future growth potential of market across different segments, such as product types, application and regions. The years considered for the study are:
Historical Year – 2014 & 2015
Base Year – 2015
Estimated Year – 2016
Projected Year – 2025
Companies reported in this report are: Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers of Biosimilars
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES
Recombinant Glycosylated Proteins
Recombinant Non-Glycosylated Proteins
Recombinant Peptides
GLOBAL BIOSIMILARS MARKET, BY APPLICATION
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
GLOBAL BIOSIMILARS MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
GLOBAL BIOSIMILARS MARKET, GEOGRAPHIC ANALYSIS
Further Breakdown of The North America Biosimilars Market
U.S.
Canada
Further Breakdown of The Europe Biosimilars Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Biosimilars Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Biosimilars Market
Middle East and Africa
Latin America

TABLE OF CONTENT
BIOSIMILARS MARKET OVERVIEW
Study Scope
Base Year
Assumption and Methodology
EXECUTIVE SUMMARY
Key Market Facts
Geographical Scenario
Companies in the Market
BIOSIMILARS MARKETKEY MARKET TRENDS
Market Drivers
Impact Analysis of Market Drivers
Market Restraints
Impact Analysis of Market Restraints
Market Opportunities
Market Future Trends
BIOSIMILARS MARKETINDUSTRY STUDY
Pipeline Therapeutic Analysis
Pricing Analysis
New Introduction by Leading Companies
BIOSIMILARS MARKET LANDSCAPE
Market Share Analysis
Key Innovators
BIOSIMILARS MARKET – BY PRODUCT TYPES:
Overview
Recombinant Glycosylated Proteins
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Recombinant Non-Glycosylated Proteins
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Recombinant Peptides
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
BIOSIMILARS MARKET – BY APPLICATION:
Overview
Oncology
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Blood Disorders
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Infectious Diseases
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Autoimmune Diseases
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Other Diseases
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
BIOSIMILARS MARKET– BY GEOGRAPHY
Introduction
North America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
U.S.
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Canada
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
France
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Germany
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Rest of Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Asia Pacific (APAC)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
China
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
India
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Rest of APAC
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Rest of the World
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Latin America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Middle East and Africa
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
KEY VENDOR ANALYSIS
Astra Zeneca, plc
Company Overview
SWOT Analysis
Key Developments
Amgen, Inc.
Company Overview
SWOT Analysis
Key Developments
Pfizer, Inc.
Company Overview
SWOT Analysis
Key Developments
Biocon Ltd.
Company Overview
SWOT Analysis
Key Developments
Novartis AG
Company Overview
SWOT Analysis
Key Developments
Teva Pharma
Company Overview
SWOT Analysis
Key Developments
STADA AG
Company Overview
SWOT Analysis
Key Developments
360 DEGREE ANALYSTVIEW
APPENDIX
Research Methodology
Abbreviations
Disclaimer
Contact Us
SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the Biosimilars Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the Biosimilars Market by its major segments, which include the type, end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT:
Understanding of the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the competitive landscape of this market
In-depth analysis of the key factors are propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market grow
KEY PREMIUM INSIGHTS:
Rising consumer wealth and income levels, increasing government and patient awareness, and a trend towards healthier lifestyles are anticipated to boost health care spending to around 8.1% in 2014-2018 in Asia Pacific
Biosimilars require high costs of investment and require a time frame to 7-8 years to enter the market
Economic expansion and government focus on broader welfare policies will drive the market for biosimilars.

Enterprise User Licence Price (USD)Single User Licence Price (USD)
Clear